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ABSTRACT 
The Asian venous thromboembolism (VTE) prophylaxis guidelines were first published in 
2012. Since its first edition, the Asian Venous Thrombosis Forum (AVTF) working group 
have updated the Asian VTE epidemiology and reviewed issues that were not addressed in 
the previous guidelines. The authors noted that the rising incidence of VTE across Asia may 
be attributable to aging population, dietary changes, and increasing incidence of obesity and 
diabetes. The new additions in the guideline include role of thrombophilia in VTE, bleeding 
risk in Asians, individual risk assessment, updates in the prevention of VTE in medically ill, 
bariatric surgery, cancer, orthopedic and trauma patients. The influence of primary 
thrombophilia in perioperative VTE is still unclear. The secondary risk factors, however, are 
similar between Asians and Caucasians. The group found no evidence of increased risk of 
bleeding while using pharmacological agents, including the use of novel anti-coagulants. At 
present, Caprini risk assessment model is widely used for individual risk assessment. Further 
validation of this model is needed in Asia. In medically ill patients, pharmacological agents 
are preferred if there is no bleeding risk. Intermittent pneumatic compression device (IPC) is 
recommended in patients with bleeding risk but we do not recommend using graduated 
compressive stockings. In bariatric patients, data on VTE is lacking in Asia. We recommend 
following current international guidelines. A high index of suspicion should be maintained 
during postbariatric surgery to detect and promptly treat portomesenteric venous thrombosis. 
Different cancer types have different thrombotic risks and the types of surgery influence to a 
large extent the overall VTE risk. Cancer patients should receive further risk assessment. In 
patients with higher thrombotic risk, either due to predisposing risk or concomitant surgery, 
low molecular weight heparin is indicated. Different countries appear to have different 
incidence of VTE following trauma and major orthopedic surgery. We recommend 
mechanical prophylaxis using IPC as the main method and additional pharmacological 
prophylaxis if the thrombotic risk is high. As for obstetric practice, we propose adherence to 
the UK Greentop guideline that is widely accepted and utilized across Asia. To improve VTE 
thromboprophylaxis implementation in the region, we propose that there should be better 
health education, establishment of hospital-based guidelines and multidisciplinary 
collaboration. 
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